Sitka Biopharma, a spin-off company of CDRD Ventures Inc., has developed a novel polymer platform technology that improves drug absorption for cancer treatments. Its lead candidate is a formulation that allows taxane drugs to adhere and penetrate into the bladder wall, enhancing treatment benefit for bladder cancer. Preclinical proof-of-concept has been established and the company’s near term goal is to gain regulatory approval to commence clinical trials.
View Top Employees from Sitka Biopharma| Website | http://www.sitkabiopharma.com |
| Revenue | $1 million |
| Funding | $1.9 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2013 |
| Address | 2500 1075 West Georgia, Vancouver, British Columbia V6E 3C9, CA |
| Phone | (604) 827-1226 |
| Industry | Biotechnology Research, Business Services General, Biopharma, Business Services, Biotechnology, Health Care, Science and Engineering, Pharmaceutical |
| Competitors | AVEO Oncology, Anaeropharma Science, Inc., Boston Biomedical, Inc., Lengo Therapeutics, Selecta Biosciences |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Sitka Biopharma employee's phone or email?
Sitka Biopharma Questions
The Sitka Biopharma annual revenue was $1 million in 2024.
Sitka Biopharma is based in Vancouver, British Columbia.
The NAICS codes for Sitka Biopharma are [32, 3254, 325, 32541].
The SIC codes for Sitka Biopharma are [28, 283].
Related Companies
